Cargando…
438. Characteristics and Epidemiology of a Native American Community with a High Prevalence of COVID-19
BACKGROUND: COVID research and reporting has focused on large urban populations. However, limited data suggests that rural Native American (NA) populations are disparately impacted. We serve a well-defined NA population of ≈18,000 that is relatively geographically isolated in the White Mountains of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776644/ http://dx.doi.org/10.1093/ofid/ofaa439.631 |
_version_ | 1783630729932963840 |
---|---|
author | Bratsch, Nicole A Campbell, Natalie McAuley, James Close, Ryan M |
author_facet | Bratsch, Nicole A Campbell, Natalie McAuley, James Close, Ryan M |
author_sort | Bratsch, Nicole A |
collection | PubMed |
description | BACKGROUND: COVID research and reporting has focused on large urban populations. However, limited data suggests that rural Native American (NA) populations are disparately impacted. We serve a well-defined NA population of ≈18,000 that is relatively geographically isolated in the White Mountains of eastern Arizona. Our first case SARS-CoV-2 was confirmed April 1(st). We have since confirmed an attack rate significantly higher than most of the United States. We provide testing and case trends in addition to characteristics of the first 800 cases. METHODS: We sequentially reviewed the charts of all laboratory-confirmed COVID-19 patients from April 1 to June 3, 2020. In addition to calculating prevalence and rates, we provided summary statistics that were used to describe testing breakdown, demographics, symptoms, and co-morbidities. RESULTS: From April 1 to June 3, we tested 2,662 persons, of which 884 (33.2%) were positive. The estimated prevalence of the time of writing is 4.9% and the rate of 4,911 per 100,000 persons. Data compiled from the first 800 laboratory-confirmed patients is summarized in table 1. Median age for confirmed cases was 40.6 (IQR 28–54). 555 cases (72.1%) were symptomatic. The most common symptoms were cough (67.7%), subjective fever (39.5%), and muscle aches (36.8%). 30.6% of confirmed cases were asymptomatic at the time of testing. The majority of cases were among persons aged 30–39 years (22.9%). Some of the most common comorbidities in confirmed cases included cardiovascular disease (30.4%), substance abuse (30.1%), and diabetes (25.0%). There were 18 (2.04%) deaths. Clinical findings among symptomatic patients [Image: see text] CONCLUSION: We observed a significantly higher prevalence (10-times) and attack rate of (17-times) COVID-19 in a well-defined NA population, when compared to the general Arizona population. We provide characteristics of these cases and report that nearly a third were asymptomatic at the time of testing. More research is needed to understand the rapid spread of COVID-19 in vulnerable rural communities. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7776644 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77766442021-01-07 438. Characteristics and Epidemiology of a Native American Community with a High Prevalence of COVID-19 Bratsch, Nicole A Campbell, Natalie McAuley, James Close, Ryan M Open Forum Infect Dis Poster Abstracts BACKGROUND: COVID research and reporting has focused on large urban populations. However, limited data suggests that rural Native American (NA) populations are disparately impacted. We serve a well-defined NA population of ≈18,000 that is relatively geographically isolated in the White Mountains of eastern Arizona. Our first case SARS-CoV-2 was confirmed April 1(st). We have since confirmed an attack rate significantly higher than most of the United States. We provide testing and case trends in addition to characteristics of the first 800 cases. METHODS: We sequentially reviewed the charts of all laboratory-confirmed COVID-19 patients from April 1 to June 3, 2020. In addition to calculating prevalence and rates, we provided summary statistics that were used to describe testing breakdown, demographics, symptoms, and co-morbidities. RESULTS: From April 1 to June 3, we tested 2,662 persons, of which 884 (33.2%) were positive. The estimated prevalence of the time of writing is 4.9% and the rate of 4,911 per 100,000 persons. Data compiled from the first 800 laboratory-confirmed patients is summarized in table 1. Median age for confirmed cases was 40.6 (IQR 28–54). 555 cases (72.1%) were symptomatic. The most common symptoms were cough (67.7%), subjective fever (39.5%), and muscle aches (36.8%). 30.6% of confirmed cases were asymptomatic at the time of testing. The majority of cases were among persons aged 30–39 years (22.9%). Some of the most common comorbidities in confirmed cases included cardiovascular disease (30.4%), substance abuse (30.1%), and diabetes (25.0%). There were 18 (2.04%) deaths. Clinical findings among symptomatic patients [Image: see text] CONCLUSION: We observed a significantly higher prevalence (10-times) and attack rate of (17-times) COVID-19 in a well-defined NA population, when compared to the general Arizona population. We provide characteristics of these cases and report that nearly a third were asymptomatic at the time of testing. More research is needed to understand the rapid spread of COVID-19 in vulnerable rural communities. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776644/ http://dx.doi.org/10.1093/ofid/ofaa439.631 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Bratsch, Nicole A Campbell, Natalie McAuley, James Close, Ryan M 438. Characteristics and Epidemiology of a Native American Community with a High Prevalence of COVID-19 |
title | 438. Characteristics and Epidemiology of a Native American Community with a High Prevalence of COVID-19 |
title_full | 438. Characteristics and Epidemiology of a Native American Community with a High Prevalence of COVID-19 |
title_fullStr | 438. Characteristics and Epidemiology of a Native American Community with a High Prevalence of COVID-19 |
title_full_unstemmed | 438. Characteristics and Epidemiology of a Native American Community with a High Prevalence of COVID-19 |
title_short | 438. Characteristics and Epidemiology of a Native American Community with a High Prevalence of COVID-19 |
title_sort | 438. characteristics and epidemiology of a native american community with a high prevalence of covid-19 |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776644/ http://dx.doi.org/10.1093/ofid/ofaa439.631 |
work_keys_str_mv | AT bratschnicolea 438characteristicsandepidemiologyofanativeamericancommunitywithahighprevalenceofcovid19 AT campbellnatalie 438characteristicsandepidemiologyofanativeamericancommunitywithahighprevalenceofcovid19 AT mcauleyjames 438characteristicsandepidemiologyofanativeamericancommunitywithahighprevalenceofcovid19 AT closeryanm 438characteristicsandepidemiologyofanativeamericancommunitywithahighprevalenceofcovid19 |